Vestas Wind Systems Shares Surge Post Q2 Resultsby Mark Eisenberg 18.08.2024Vestas' Q2 results meet expectations; strong order intake and pricing boost outlook for second half of 2023.
Tecan Revises 2024 Outlook Amid Market Challengesby Mark Eisenberg 18.08.2024Tecan reports lower H1 2024 sales, revises full-year outlook due to biopharma sector weakness and market challenges in China.
BREIN Enforces Copyright on AI Training Datasetby Mark Eisenberg 18.08.2024BREIN stops unauthorized AI dataset use from books, films, and news.
What Financial Entities Need to Know About DORAby Mark Eisenberg 17.08.2024DORA mandates EU firms enhance ICT risk management by Jan 2025.
Tether CEO Urges Investment in Bitcoin Amid Tensionsby John Darbie 17.08.2024Paolo Ardoino advocates for Bitcoin and gold due to rising geopolitical and economic uncertainties.
Spirit Aero CEO’s $28.5M Golden Parachute Dealby Mark Eisenberg 15.08.2024CEO Patrick Shanahan to receive $28.5M after Spirit merger with Boeing. Includes cash, stock, and perks.
Genmab Reports 36% Revenue Growth in H1 2024by Mark Eisenberg 15.08.2024Genmab's H1 2024 results show 36% revenue growth; DARZALEX sales surge, and strategic acquisition of ProfoundBio boosts future potential.
RYVYL Inc. Q2 2024: International Growth Surgeby Mark Eisenberg 15.08.2024RYVYL Inc. reports 134% international revenue growth in Q2 2024, offsetting North American decline.
Global Stocks Rise on Fed Rate Cut Hopesby Mark Eisenberg 15.08.2024Stock markets gain globally as investors anticipate a Federal Reserve interest rate cut amid positive economic indicators.
Glanbia Sees Strong H1 2024 Growth, EPS Up 12.4%by Mark Eisenberg 15.08.2024Glanbia reports 12.4% EPS growth in H1 2024 amid strong demand and strategic acquisitions.